Last updated: 18 July 2019 at 5:14pm EST

Michael A. Pfaller Net Worth




The estimated Net Worth of Michael A. Pfaller is at least $35.5 Thousand dollars as of 8 May 2015. Michael Pfaller owns over 15,440 units of T2 Biosystems Inc stock worth over $35,512 and over the last 9 years Michael sold TTOO stock worth over $0.

Michael Pfaller TTOO stock SEC Form 4 insiders trading

Michael has made over 1 trades of the T2 Biosystems Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Michael exercised 15,440 units of TTOO stock worth $165,054 on 8 May 2015.

The largest trade Michael's ever made was exercising 15,440 units of T2 Biosystems Inc stock on 8 May 2015 worth over $165,054. On average, Michael trades about 7,720 units every 0 days since 2015. As of 8 May 2015 Michael still owns at least 15,440 units of T2 Biosystems Inc stock.

You can see the complete history of Michael Pfaller stock trades at the bottom of the page.



What's Michael Pfaller's mailing address?

Michael's mailing address filed with the SEC is 101, Hartwell Avenue, Lexington, Middlesex County, Massachusetts, 02421, United States.

Insiders trading at T2 Biosystems Inc

Over the last 10 years, insiders at T2 Biosystems Inc have traded over $18,971,153 worth of T2 Biosystems Inc stock and bought 5,875,341 units worth $59,722,018 . The most active insiders traders include Adrian M Jones, Group L.P.Crg Partners Iii ..., and Thomas J. Carella. On average, T2 Biosystems Inc executives and independent directors trade stock every 20 days with the average trade being worth of $764,499. The most recent stock trade was executed by John J Iii Sperzel on 24 February 2024, trading 67 units of TTOO stock currently worth $154.



What does T2 Biosystems Inc do?

t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www



What does T2 Biosystems Inc's logo look like?

T2 Biosystems Inc logo

Complete history of Michael Pfaller stock trades at T2 Biosystems Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
8 May 2015 Michael A. Pfaller
Chief Medical Officer
Option 15,440 $10.69 $165,054
8 May 2015
15,440


T2 Biosystems Inc executives and stock owners

T2 Biosystems Inc executives and other stock owners filed with the SEC include: